Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Bridging Study to Assess Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population

NCT03336593 is registered in ClinicalTrials.gov with PT Bio Farma as lead sponsor.

NCT NCT03336593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03336593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Bridging Study to Assess Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population
Lead sponsor
PT Bio Farma
Phase
Phase 2
Overall status
Completed
Start date
November 21, 2017
Completion date
November 30, 2018
Enrollment
810 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

safety issues